Azimuth Capital Management LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 11 filers reported holding Novozymes A/S in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Azimuth Capital Management LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q4 2016$1,520,000
-25.3%
44,010
-4.9%
0.13%
-26.6%
Q3 2016$2,036,000
+3.1%
46,280
+11.9%
0.18%0.0%
Q2 2016$1,974,000
+13.8%
41,360
+7.3%
0.18%
+6.6%
Q1 2016$1,735,000
-7.3%
38,540
-0.9%
0.17%
-9.3%
Q4 2015$1,871,000
+22.3%
38,875
+10.6%
0.18%
+14.4%
Q3 2015$1,530,000
+4.9%
35,145
+14.6%
0.16%
+12.7%
Q2 2015$1,458,00030,6800.14%
Other shareholders
Novozymes A/S shareholders Q2 2015
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders